Craig C. Hopkinson Alkermes Plc. (ALKS) insider trading activity

Craig C. Hopkinson is EVP R&D, Chief Medical Officer of Alkermes plc.. Currently has a direct ownership of 57,875 shares of ALKS, which is worth approximately $2.08 Million. The most recent transaction as insider was on Feb 22, 2023, when has been sold 5,345 shares (Ordinary Shares) at a price of $27.77 per share, resulting in proceeds of $148,430. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.9K

30.52% 3M change

34.19% 12M change

Total Value Held $2.08 Million

Craig C. Hopkinson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 22 2023	SELL Payment of exercise price or tax liability	$148,430 $27.77 p/Share	5,345 Reduced 8.63%	56,559 Ordinary Shares
Feb 22 2023	BUY Exercise of conversion of derivative security	-	12,038 Added 16.28%	61,904 Ordinary Shares
Feb 21 2023	SELL Payment of exercise price or tax liability	$84,781 $27.77 p/Share	3,053 Reduced 5.77%	49,866 Ordinary Shares
Feb 21 2023	BUY Exercise of conversion of derivative security	-	6,875 Added 11.5%	52,919 Ordinary Shares
Feb 20 2023	SELL Payment of exercise price or tax liability	$289,289 $28.07 p/Share	10,306 Reduced 18.29%	46,044 Ordinary Shares
Feb 20 2023	BUY Grant, award, or other acquisition	-	22,195 Added 29.69%	52,570 Ordinary Shares
Feb 20 2023	BUY Exercise of conversion of derivative security	-	10,095 Added 22.81%	34,155 Ordinary Shares
Feb 18 2023	SELL Payment of exercise price or tax liability	$74,553 $28.07 p/Share	2,656 Reduced 9.94%	24,060 Ordinary Shares
Feb 18 2023	BUY Exercise of conversion of derivative security	-	8,722 Added 24.61%	26,716 Ordinary Shares
Feb 23 2022	SELL Open market or private sale	$296,699 $24.76 p/Share	11,983 Reduced 39.97%	17,994 Ordinary Shares
Feb 22 2022	SELL Payment of exercise price or tax liability	$88,510 $25.01 p/Share	3,539 Reduced 10.56%	29,977 Ordinary Shares
Feb 22 2022	BUY Exercise of conversion of derivative security	-	12,037 Added 26.42%	33,516 Ordinary Shares
Feb 21 2022	SELL Payment of exercise price or tax liability	$50,712 $25.08 p/Share	2,022 Reduced 8.6%	21,479 Ordinary Shares
Feb 21 2022	BUY Exercise of conversion of derivative security	-	6,875 Added 22.63%	23,501 Ordinary Shares
Feb 20 2022	SELL Payment of exercise price or tax liability	$74,387 $25.08 p/Share	2,966 Reduced 15.14%	16,626 Ordinary Shares
Feb 20 2022	BUY Exercise of conversion of derivative security	-	10,096 Added 34.01%	19,592 Ordinary Shares
Feb 18 2022	SELL Open market or private sale	$58,042 $25.17 p/Share	2,306 Reduced 19.54%	9,496 Ordinary Shares
Feb 16 2022	SELL Payment of exercise price or tax liability	$28,639 $26.79 p/Share	1,069 Reduced 8.31%	11,802 Ordinary Shares
Feb 16 2022	BUY Exercise of conversion of derivative security	-	3,375 Added 20.77%	12,871 Ordinary Shares
Sep 14 2021	SELL Payment of exercise price or tax liability	$172,798 $30.6 p/Share	5,647 Reduced 37.29%	9,496 Ordinary Shares
Sep 14 2021	BUY Grant, award, or other acquisition	-	15,143 Added 50.0%	15,143 Ordinary Shares
Jun 09 2021	SELL Open market or private sale	$21,697 $24.6 p/Share	882 Reduced 100.0%	0 Ordinary Shares
Jun 07 2021	SELL Payment of exercise price or tax liability	$8,648 $23.5 p/Share	368 Reduced 29.44%	882 Ordinary Shares
Jun 07 2021	BUY Exercise of conversion of derivative security	-	1,250 Added 50.0%	1,250 Ordinary Shares
Apr 15 2021	SELL Open market or private sale	$570,302 $19.72 p/Share	28,920 Reduced 100.0%	0 Ordinary Shares

Also insider at

ALBO

ALBIREO PHARMA, INC. Healthcare

Director

CCH